EPIX Pharmaceuticals
Biotechnology ResearchUnited States51-200 Employees
Learn about working at EPIX Pharmaceuticals. Join LinkedIn today for free. See who you know at EPIX Pharmaceuticals, leverage your professional network, and get hired.
Growing Market Presence Epix Pharmaceuticals operates within the competitive biotechnology research industry, targeting collaborations and partnerships with larger pharmaceutical companies to expand its market reach and accelerate product development.
Product Development Potential With an established revenue range between 10 million and 50 million, there are opportunities to offer specialized biotech solutions or research tools that can help the company innovate and increase its market share.
Tech Engagement The company's use of digital analytics and web technologies indicates openness to innovative technological integrations, opening avenues for advanced biotech data management, lab automation, or digital research solutions.
Talent Acquisition Opportunities Epix Pharmaceuticals has a moderate-sized team of up to 200 employees, presenting opportunities to provide recruitment, training, or HR solutions to support its growth and attract top research talent.
Industry Alignment Positioned alongside major pharma giants, Epix presents an ideal partner for joint research initiatives, licensing agreements, or co-development projects to enhance its capabilities and competitiveness.
EPIX Pharmaceuticals uses 5 technology products and services including jQuery, SWFObject, Google Analytics, and more. Explore EPIX Pharmaceuticals's tech stack below.
| EPIX Pharmaceuticals Email Formats | Percentage |
| FLast@epixpharma.com | 50% |
| FLast@epixpharma.com | 50% |
Biotechnology ResearchUnited States51-200 Employees
Learn about working at EPIX Pharmaceuticals. Join LinkedIn today for free. See who you know at EPIX Pharmaceuticals, leverage your professional network, and get hired.
EPIX Pharmaceuticals's revenue is estimated to be in the range of $10M$25M
EPIX Pharmaceuticals's revenue is estimated to be in the range of $10M$25M